ReviewPathogens (Basel, Switzerland)2024
Exploring Extended-Spectrum Beta-Lactamase (ESBL)-Producing
Review in Pathogens (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.
- Quantifying antimicrobial resistance in food-producing animals in North America.Frontiers in microbiology · 2025Pooled it
- A Systematic Review of β-Lactamase and Carbapenemase-ProducingVeterinary sciences · 2026Review
- Whole-Genome Sequencing ofMicroorganisms · 2026Article
- Prevalence and Genomic Insight of Extended-Spectrum β-Lactamase-ProducingFoods (Basel, Switzerland) · 2026Article
- Diversity and Antimicrobial Resistance Profiles of ESBL-ProducingPathogens (Basel, Switzerland) · 2026Article
- Lineage-aware comparison of extended-spectrumMicrobial genomics · 2026Article
- A One Health view of antimicrobial resistance in North Africa: Meta-analysis of ESBL-producing Enterobacteriaceae across sectors.One health (Amsterdam, Netherlands) · 2026Review
- Whole genome sequencing-based characterization of Escherichia coli isolated from raw beef in selected butcher shops in Addis Ababa and Burayu, Ethiopia.Scientific reports · 2026Article
- ESBL and carbapenemase-producing enteric pathogens in animal-origin foods: a one health perspective.Folia microbiologica · 2026Review
- Antimicrobial Susceptibility and Characterization of Extended-Spectrum β-Lactamases inMicroorganisms · 2026Article
- Systematic Review and Meta-Analysis of Extended-Spectrum Beta-Lactamase-Producing (ESBL)Antibiotics (Basel, Switzerland) · 2026Review
- Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli from abattoir and live bird market wastewaters in Kaduna State, Nigeria.BMC veterinary research · 2026Article
- High prevalence of CTX-M-1 and CTX-M-15 extended-spectrum β-lactamase-producingVeterinary world · 2026Article
- Evolutionary trends and genetic determinants of third-generation cephalosporin resistance inFrontiers in microbiology · 2026Article
- Surveillance of CTX-M group 1-producingFrontiers in microbiology · 2026Article
- Seasonal prevalence of extended-spectrum β-lactamase-producing bacteria in food-chain animals, humans, and the surrounding environment in Fayoum governorate: a one health approach.Frontiers in microbiology · 2026Article
- Occurrence of extended- spectrum β-lactamases and ertapenem- mono- resistance inOne health (Amsterdam, Netherlands) · 2025Article
- Co-Occurrence and Molecular Characterization of ESBL-Producing and Colistin-ResistantFoods (Basel, Switzerland) · 2025Article
- Occurrence and Molecular Characterization of Extended-Spectrum Beta-Lactamase (ESBL)-ProducingAntibiotics (Basel, Switzerland) · 2025Article
- Antimicrobial resistance and characterization of ESBL-producing Escherichia coli from poultry and cattle in Isfahan, Iran.BMC veterinary research · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobials serve as crucial treatments in both veterinary and human medicine, aiding in the control and prevention of infectious diseases. However, their misuse or overuse has led to the emergence of antimicrobial resistance, posing a significant threat to public health. This review focuses on extended-spectrum beta-lactamase (ESBL)-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.